P

Inventor

OR YAT SUN

US336 patents
⚠️ This page may combine multiple inventors who share the name “OR YAT SUN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ENANTA PHARM INC

30 patents
US7176208B2Feb 13, 2007

Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

ENANTA PHARM INC111 citations99
US7635683B2Dec 22, 2009

Quinoxalinyl tripeptide hepatitis C virus inhibitors

ENANTA PHARM INC75 citations98
US9957281B2May 1, 2018

Benzodiazepine derivatives as RSV inhibitors

ENANTA PHARM INC32 citations97
US6878691B2Apr 12, 2005

6-11 bicyclic ketolide derivatives

ENANTA PHARM INC73 citations97
US6680299B2Jan 20, 2004

4'-substituted leucomycins

ENANTA PHARM INC71 citations97
US7125845B2Oct 24, 2006

Aza-peptide macrocyclic hepatitis C serine protease inhibitors

ENANTA PHARM INC57 citations95
US10865215B2Dec 15, 2020

Benzodiazepine derivatives as RSV inhibitors

ENANTA PHARM INC16 citations94
US10683279B2Jun 16, 2020

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

ENANTA PHARM INC13 citations94
US10538532B2Jan 21, 2020

Hepatitis B antiviral agents

ENANTA PHARM INC17 citations94
US10428070B2Oct 1, 2019

Hepatitis B antiviral agents

ENANTA PHARM INC24 citations94
US10398706B2Sep 3, 2019

Heteroaryldiazepine derivatives as RSV inhibitors

ENANTA PHARM INC26 citations94
US10358441B2Jul 23, 2019

Processes for the preparation of benzodiazepine derivatives

ENANTA PHARM INC27 citations94
US10189846B2Jan 29, 2019

Hepatitis B antiviral agents

ENANTA PHARM INC25 citations94
US10179131B2Jan 15, 2019

Hepatitis B antiviral agents

ENANTA PHARM INC27 citations94
US10179792B2Jan 15, 2019

Hepatitis B antiviral agents

ENANTA PHARM INC17 citations94
US10034893B2Jul 31, 2018

5, 6-D2 uridine nucleoside/tide derivatives

ENANTA PHARM INC34 citations94
US8846638B2Sep 30, 2014

Macrocyclic nucleoside phosphoramidate derivatives

ENANTA PHARM INC34 citations94
US7582605B2Sep 1, 2009

Phosphorus-containing hepatitis C serine protease inhibitors

ENANTA PHARM INC59 citations94
US7368452B2May 6, 2008

Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

ENANTA PHARM INC35 citations94
US7687459B2Mar 30, 2010

Arylalkoxyl hepatitis C virus protease inhibitors

ENANTA PHARM INC26 citations93
US7189704B2Mar 13, 2007

6-11 bicyclic ketolide derivatives

ENANTA PHARM INC15 citations93
US7022679B2Apr 4, 2006

Processes for the preparation of 6-11 bicyclic erythromycin derivatives

ENANTA PHARM INC21 citations93
US6764998B1Jul 20, 2004

6,11-4C-bicyclic 9a-azalide derivatives

ENANTA PHARM INC39 citations93
US7605126B2Oct 20, 2009

Acylaminoheteroaryl hepatitis C virus protease inhibitors

ENANTA PHARM INC38 citations92
US7566719B2Jul 28, 2009

Quinoxalinyl macrocyclic hepatitis C serine protease inhibitors

ENANTA PHARM INC20 citations92
US7273853B2Sep 25, 2007

6-11 bicyclic ketolide derivatives

ENANTA PHARM INC35 citations92
US7129221B2Oct 31, 2006

6,11-bicyclic erythromycin derivatives

ENANTA PHARM INC25 citations92
US7012065B2Mar 14, 2006

Cyclosporins for the treatment of immune disorders

ENANTA PHARM INC41 citations92
US6784156B2Aug 31, 2004

Cyclosporins for the treatment of respiratory diseases

ENANTA PHARM INC39 citations92
US6645941B1Nov 11, 2003

6,11-3C-bicyclic 9a-azalide derivatives

ENANTA PHARM INC41 citations92

ABBOTT LAB

17 patents
US5866549AFeb 2, 1999

6-O-substituted ketolides having antibacterial activity

ABBOTT LAB176 citations99
US5922683AJul 13, 1999

Multicyclic erythromycin derivatives

ABBOTT LAB101 citations97
US5457111AOct 10, 1995

Macrocyclic immunomodulators

ABBOTT LAB160 citations97
US6124269ASep 26, 2000

2-Halo-6-O-substituted ketolide derivatives

ABBOTT LAB97 citations96
US6075133AJun 13, 2000

6-O-substituted antibacterial erythromycin ketolides and methods of making

ABBOTT LAB43 citations96
US5672605ASep 30, 1997

Macrolide immunomodulators

ABBOTT LAB69 citations96
US5583139ADec 10, 1996

Marcolide immunomodulators

ABBOTT LAB65 citations96
US6054435AApr 25, 2000

6-O-substituted macrolides having antibacterial activity

ABBOTT LAB74 citations95
US6420535B1Jul 16, 2002

6-O-carbamate ketolide derivatives

ABBOTT LAB35 citations93
US6034069AMar 7, 2000

3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity

ABBOTT LAB28 citations93
US5780605AJul 14, 1998

6,9-bridged erythromycin derivatives

ABBOTT LAB37 citations93
US5604234AFeb 18, 1997

Substituted thiol macrolactam immunomodulators

ABBOTT LAB27 citations93
US5563172AOct 8, 1996

Macrocyclic amide and urea immunomodulators

ABBOTT LAB25 citations93
US5561137AOct 1, 1996

Thio-heterocyclic macrolactam immunomodulators

ABBOTT LAB26 citations93
US5534632AJul 9, 1996

Macrocyclic carbamate immunomodulators

ABBOTT LAB24 citations93
US6946446B2Sep 20, 2005

Anti-infective agents useful against multidrug-resistant strains of bacteria

ABBOTT LAB21 citations92
US6355620B1Mar 12, 2002

C-2 modified erythromycin derivatives

ABBOTT LAB38 citations92

QIU YAO-LING

1 patent

WANG GUOQIANG

1 patent

OR YAT SUN

1 patent

Showing the top 50 of 336 patents by PatentIndex Score.